RESUMO
Prevalence of hepatitis G virus among Tunisian blood donors Hepatitis G virus (GBV-C/HGV) is a recently identified virus which occurs worldwide. The prevalence of GBV-C/HGV in Tunisia has not been previously studied. We aimed to assess the prevalence of GBV-C/HGV infection in Tunisian blood donors. A total of 912 blood donors were tested for anti-E2 antibodies of GBV-C/HGV by enzyme-linked immunosorbent assay and 600 were tested by reverse transcriptase polymerase chain reaction. GBV-C/HGV RNA was found in 5.3% of the sample and HGV antibodies occurred in 4.9%. A correlation was noticed between GBV-C/HGV infection and hepatitis C virus (P = 0.006). The prevalence of GBV-C/HGV is similar to that reported worldwide.
Assuntos
Doadores de Sangue/estatística & dados numéricos , Vírus GB C , Hepatite Viral Humana/epidemiologia , Hepatite Viral Humana/virologia , Adolescente , Adulto , Distribuição por Idade , Comorbidade , DNA Viral/análise , DNA Viral/genética , Ensaio de Imunoadsorção Enzimática , Feminino , Vírus GB C/genética , Vírus GB C/imunologia , Infecções por HIV/complicações , Infecções por HIV/epidemiologia , Anticorpos Anti-Hepatite/sangue , Hepatite B/complicações , Hepatite B/epidemiologia , Hepatite C/complicações , Hepatite C/epidemiologia , Hepatite Viral Humana/sangue , Hepatite Viral Humana/complicações , Hepatite Viral Humana/diagnóstico , Humanos , Masculino , Programas de Rastreamento/métodos , Pessoa de Meia-Idade , Vigilância da População , RNA Viral/análise , RNA Viral/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Fatores de Risco , Estudos Soroepidemiológicos , Tunísia/epidemiologiaRESUMO
Prevalence of hepatitis G virus among Tunisian blood donors Hepatitis G virus [GBV-C/HGV] is a recently identified virus which occurs worldwide. The prevalence of GBV-C/HGV in Tunisia has not been previously studied. We aimed to assess the prevalence of GBV-C/HGV infection in Tunisian blood donors. A total of 912 blood donors were tested for anti-E2 antibodies of GBV-C/HGV by enzyme-linked immunosorbent assay and 600 were tested by reverse transcriptase polymerase chain reaction. GBV-C/HGV RNA was found in 5.3% of the sample and HGV antibodies occurred in 4.9%. A correlation was noticed between GBV-C/HGV infection and hepatitis C virus [P = 0.006]. The prevalence of GBV-C/HGV is similar to that reported worldwide
